Somerville, MA, United States of America

Arnaud Gutierrez

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arnaud Gutierrez: Innovator in DNA Detection and Antibiotic Sensitization

Introduction

Arnaud Gutierrez is a notable inventor based in Somerville, MA (US). He has made significant contributions to the fields of molecular biology and pharmacology, holding 2 patents that focus on innovative methods for DNA damage detection and antibiotic sensitization.

Latest Patents

Gutierrez's latest patents include groundbreaking work on "Single-stranded break detection in double-stranded DNA." This patent relates to compositions and methods for detecting single-stranded breaks (SSBs) in double-stranded DNA, including genomic DNA. The approach allows for the precise measurement of SSB damage in DNA and is compatible with next-generation sequencing technologies. Another significant patent is for the "Sensitization of bacterial cells to quinolone antibiotics." This invention provides pharmaceutical compositions and kits that sensitize microorganisms to quinolone antibiotics. It includes methods for reducing the density-dependent persistence of antibiotic-resistant microorganisms, which is crucial for treating infections from high-density bacterial cultures.

Career Highlights

Throughout his career, Gutierrez has worked with prestigious institutions such as the Massachusetts Institute of Technology and The Broad Institute, Inc. His work has had a profound impact on the understanding and treatment of bacterial infections and DNA damage.

Collaborations

He has collaborated with talented individuals like Sarah DiIorio and Joshua Elacqua, contributing to the advancement of research in his field.

Conclusion

Arnaud Gutierrez is a distinguished inventor whose work in DNA detection and antibiotic sensitization continues to influence the scientific community. His innovative patents reflect his commitment to addressing critical challenges in molecular biology and pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…